Literature DB >> 1522385

Nitric oxide production by tumor targets in response to TNF: paradoxical correlation with susceptibility to TNF-mediated cytotoxicity without direct involvement in the cytotoxic mechanism.

D J Fast1, R C Lynch, R W Leu.   

Abstract

Tumor necrosis factor (TNF) is selectively cytotoxic for some tumor cells in vivo and in vitro. We determined whether TNF-mediated cytotoxicity for TNF-sensitive tumor targets was related to TNF-stimulated production of NO by the tumor cell itself. We found that a cell line that was sensitive to TNF-mediated cytotoxicity produced NO in response to TNF as measured by the accumulation of nitrite in the supernatants of TNF-stimulated cells. Production of NO in response to TNF was inhibited by the competitive substrate inhibitor, NG-monomethyl-L-arginine (NMMA). The kinetics of NO production in response to TNF indicated that most of the NO was produced during the first 24 h and peaked after 48 h of culture and that TNF-stimulated NO production was dose dependent. TNF-resistant cell lines produced less NO than a TNF-sensitive cell line, and the amount of nitrite produced correlated with the relative sensitivity of each cell line to TNF-mediated cytotoxicity. In addition, recombinant interferon-gamma augmented the amount of NO produced in response to TNF by both sensitive and resistant cells and correspondingly enhanced the susceptibility of resistant cells to TNF cytotoxicity. Both sensitive and resistant cells were sensitive to NO, however, in that NO generated exogenously by culture in the presence of sodium nitroprusside was cytotoxic for both sensitive and resistant cells in a dose-dependent manner. We were unable, however, to demonstrate directly a role for NO in TNF-mediated cytotoxicity as NMMA- and arginine-free media provided little protection from TNF-mediated cytotoxicity. We tentatively conclude that the ability of adherent murine tumor cells to produce nitric oxide in response to TNF correlates directly with their level of sensitivity to TNF-mediated cytotoxicity, although NO thus produced appears not to be directly involved in the cytotoxic mechanism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1522385     DOI: 10.1002/jlb.52.3.255

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

1.  Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha.

Authors:  J P Maciejewski; C Selleri; T Sato; H J Cho; L K Keefer; C F Nathan; N S Young
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

2.  Role of the nitric oxide synthase pathway in inhibition of growth of interferon-sensitive and interferon-resistant Rickettsia prowazekii strains in L929 cells treated with tumor necrosis factor alpha and gamma interferon.

Authors:  J Turco; H H Winkler
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

3.  Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species.

Authors:  D A Wink; I Hanbauer; M C Krishna; W DeGraff; J Gamson; J B Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

4.  N-acetyl-L-cysteine protects endothelial cells but not L929 tumor cells from tumor necrosis factor-alpha-mediated cytotoxicity.

Authors:  H Schröder; S Warren; M J Bargetzi; S V Torti; F M Torti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

5.  Different effects of constitutive nitric oxide synthase and heme oxygenase on pulmonary or liver metastasis of colon cancer in mice.

Authors:  Takeshi Ishikawa; Norimasa Yoshida; Hiroshi Higashihara; Mamoru Inoue; Kazuhiko Uchiyama; Tomohisa Takagi; Osamu Handa; Satoshi Kokura; Yuji Naito; Takeshi Okanoue; Toshikazu Yoshikawa
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

6.  Nitric oxide enhancement of melphalan-induced cytotoxicity.

Authors:  J A Cook; M C Krishna; R Pacelli; W DeGraff; J Liebmann; J B Mitchell; A Russo; D A Wink
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Interferon regulatory factor (IRF)-1 is a master regulator of the cross talk between macrophages and L929 fibrosarcoma cells for nitric oxide dependent tumoricidal activity.

Authors:  Flavia R F Nascimento; Eliane A Gomes; Momtchilo Russo; Ana P Lepique
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

8.  Organosilicon-containing thiazole derivatives as potential lipoxygenase inhibitors and anti-inflammatory agents.

Authors:  Athina Geronikaki; Dimitra Hadjipavlou-Litina; Alla Zablotskaya; Izolda Segal
Journal:  Bioinorg Chem Appl       Date:  2007       Impact factor: 7.778

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.